Magnetic thermoradiotherapy for lung cancer: evaluation in A549−based preclinical models - Takeaways - MDSpire

Magnetic thermoradiotherapy for lung cancer: evaluation in A549−based preclinical models

  • By

  • Agnieszka Stawarska

  • Magdalena Bamburowicz-Klimkowska

  • Artur Kasprzak

  • Monika Ruzycka-Ayoush

  • Michal Bystrzejewski

  • Maria Wojewodzka

  • Michal Wieteska

  • Ireneusz P. Grudzinski

  • May 11, 2026

  • 0 min

Share

  • 1

    The study evaluates a novel strategy combining X-ray irradiation, magnetic fluid hyperthermia, and engineered nanoparticles for lung cancer treatment.

  • 2

    Engineered Fe@C-PEI-IgG-GOX nanoparticles significantly reduced lung cancer cell viability and induced DNA damage in A549 models.

  • 3

    In vivo results showed improved therapeutic outcomes when combining radiotherapy with magnetic fluid hyperthermia and targeted nanoparticles.

  • 4

    The multimodal approach enhanced treatment efficacy and prolonged time to endpoint in lung cancer models.

  • 5

    Findings support further preclinical optimization of the GOX-based magnetic nanoplatform for effective lung cancer treatment.

Original Source(s)

Magnetic thermoradiotherapy for lung cancer: evaluation in A549−based preclinical models

  • by Agnieszka Stawarska, Magdalena Bamburowicz-Klimkowska, Artur Kasprzak, Monika Ruzycka-Ayoush, Michal Bystrzejewski, Maria Wojewodzka, Michal Wieteska, Ireneusz P. Grudzinski

  • May 11, 2026

Related Content

Retraction: MicroRNA-935 directly targets FZD6 to inhibit the proliferation of human glioblastoma and correlate to glioma malignancy and prognosis

  • May 28, 2026

Novel approaches for separating graft-versus-leukemia effects from graft-versus-host disease

Prospective phase II study of frontline Helicobacter pylori eradication therapy for early-stage extragastric mucosa-associated lymphoid tissue lymphoma